Dr. Mak has served as Vice President, Biometrics of Eledon since April 2022. Prior to joining Eledon, Dr. Mak was the head of the Statistical and Quantitative Sciences for the Vaccines Therapeutic Area at Takeda, where she provided statistical leadership in the submission of dengue vaccine. Previously, she was the head of Biometrics at Mallinckrodt Pharmaceuticals where she oversaw statistical, programming and data management for a portfolio of products including Acthar® gel, Therakos and she led the submission and approval of Stratagraft® for deep partial thermal burns. Dr. Mak began her career at Schering-Plough/Merck where she directed statistical support of programs through all stages of clinical development and regulatory submission. Dr. Mak holds a Ph.D in Biostatistics from the University of Toronto and a Bachelor of Mathematics from the University of Waterloo.
Transforming Lives. One Organ at a Time.